| Bioactivity | Ligandrol (LGD-4033) is a novel nonsteroidal, oral SARM that binds to androgen receptor with high affinity (Ki of 1 nM) and selectivity.IC50 value: 1 nM (Ki, for androgen receptor) Target: androgen receptorin vitro: Ligandrol (LGD-4033), a novel nonsteroidal oral, selective androgen receptor modulator, binds androgen receptor with high affinity and selectivity.in vivo: Ligandrol (LGD-4033) has demonstrated anabolic activity in the muscle, anti-resorptive and anabolic activity in bone, and robust selectivity for muscle versus prostate In animal models. Ligandrol (LGD-4033) is well tolerated, has a long elimination half-life and dose-proportional accumulation upon multiple dosing. Ligandrol (LGD-4033) is safe, has favorable pharmacokinetic profile, and increases lean body mass even during this short period without change in prostate-specific antigen. | ||||||||||||
| Name | Ligandrol | ||||||||||||
| CAS | 1165910-22-4 | ||||||||||||
| Formula | C14H12F6N2O | ||||||||||||
| Molar Mass | 338.25 | ||||||||||||
| Appearance | 固体 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Basaria S,et al. The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men. J Gerontol A Biol Sci Med Sci. 2013 Jan;68(1):87-95. |
Ligandrol
CAS: 1165910-22-4 F: C14H12F6N2O W: 338.25
Ligandrol (LGD-4033) is a novel nonsteroidal, oral SARM that binds to androgen receptor with high affinity (Ki of 1 nM)
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.